Introduction
The distinct nature of MZBCL is further underlined by the fact that known lymphoma-associated chromosomal transMarginal zone B cell lymphoma (MZBCL) represents a distinct locations or rearrangements of the BCL1, BCL2, BCL3 and subtype of B cell non-Hodgkin's lymphoma (NHL), which BCL6 oncogenes have not been detected in these lymincludes lymphoma of the mucosa-associated lymphoid tissue phomas. 3, 16, 17, 22, 28, 29 Rearrangements of CMYC and biallelic (MALT lymphoma), 1 monocytoid B cell lymphoma, 2 and inactivation of P53 have been associated with high-grade splenic MZBCL. 3 So far, little is known about pathogenesis, transformation of gastric MALT lymphomas. 30, 31 biology, and natural history of MZBCL, in part due to the fact In the present study, 25 histologically and immunophenothat these lymphomas are relatively rare and have only typically well characterized cases of extranodal, nodal, and recently been recognized and defined as a disease entity. 4 splenic MZBCL were investigated with the recently developed The morphologic appearance is rather heterogeneous and technique of CGH. 32 CGH is a double color hybridization characterized by a mixture of centrocyte-like cells, small lymprocedure, which provides in a single experiment an overview phocytes, monocytoid B cells, plasma cells, and larger blastof genomic imbalances, such as partial or complete trisomies, monosomies, or amplifications within the tumor genome. In cessed for cytogenetic and FISH analysis, the other part was some is due to the sexes of the tumor DNA (female) and the reference used for DNA extraction and subsequent gene rearrangement DNA (male) (the combination of XX and XY DNAs was chosen for studies; remaining DNA was stored and used in the present demonstration purposes; note the difference in green fluorescence intensity of chromosomes 3 and 18 compared to the X chromosome). study for CGH analysis and gene amplification studies.
On the right side, the complete green-to-red fluorescence average pro- Comparative genomic hybridization romes and analyzed using the QUIPS software package for CGH analysis (XL System, Vysis, Stuttgart, Germany) accord-DNA was extracted from fresh, uncultured tumor tissue and from blood lymphocytes of normal individuals by phenoling to methods described elsewhere. 34 The ratio of FITC/Lissamine fluorescence intensities was calculated along chloroform extraction after proteinase K digestion according to standard methods. CGH was performed as described by each individual chromosome. Ratio values obtained from five to 10 metaphase spreads were averaged and the resulting proKallioniemi and coworkers 33 with minor modifications. Briefly, tumor DNA (test DNA) and normal DNA (reference file was plotted next to the chromosomal ideograms ( Figure 1) . Ratios above 1.20 and below 0.80 were considered to rep-DNA) were labeled by nick-translation with Biotin-16-dUTP (Boehringer, Mannheim, Germany) and Lissamine-5-dUTP resent chromosomal gain and loss, respectively. These cutoff values are based on our results from a series of control experi-(DuPont, Boston, MA, USA), respectively. In all cases, reference DNA and tumor DNA were derived from individuals ments using two normal DNAs. Over-representations were considered as high-level amplifications when the fluorescence with the same gender; in some cases an additional experiment using DNAs of different gender was performed as an internal ratio values exceeded 2.0 or when a distinct band-like hybridization signal of the tumor DNA beyond the diagnostic control for hybridization efficacy (Figure 1 ). The size of the nick-translated fragments ranged from 400 to 2000 bp. Equal threshold for over-representation was seen. The centromeric regions, heterochromatic blocks of chromosomes 1, 9 and 16, amounts (200 ng) of labeled tumor DNA and normal DNA, and 10 g of unlabeled human Cot-1 DNA (GIBCO/BRL, Gaithe satellite regions of the acrocentric chromosomes, and the Y chromosome were excluded from evaluation because of the thersburg, MD, USA) were combined in 10 l hybridization mixture (50% deionized formamide, 2 × SSC, 10% dextran abundance of highly repetitive DNA sequences. CGH results were described, according to the International System for sulfate), denatured, preannealed for 60 min, and applied to a denatured slide with normal metaphase spreads. After Human Cytogenetic Nomenclature (ISCN). 35 hybridization for 72 h at 37°C, post-hybridization washes were performed to a stringency of 0.1 × SSC at 60°C. Biotinlabeled tumor DNA was detected with one layer of avidinCytogenetic analysis fluorescein isothiocyanate (FITC) (Vector Laboratories, Burlingame, CA, USA). The slides were counterstained with Cytogenetic analysis of extranodal, lymph node, or splenic tissue was performed after unstimulated short term culture 4,6-diamidino-2-phenylindole (DAPI) and mounted with antifade solution.
(24 h) in RPMI 1640 medium supplemented with 15% fetal calf serum, glutamine, and pencillin. Peripheral blood cells Gray levels images of each of the three fluorochromes were acquired using an epifluorescence microscope (Leica DMRB;
were cultured for 3 days in the presence of 12-O-tetradecanoylphorbol-13-acetate (TPA). After exposure to colcemid, Leitz, Wetzlar, Germany) equipped with a high-resolution cooled CCD camera (Photometrics, Tuscon, AZ, USA). A harvesting was carried out according to standard methods using hypotonic KCl solution and 3:1 methanol:acetic acid three-color image was built up by overlay of the three images in pseudocolors matching the original colors of the fluorochas a fixative. Metaphases were G-banded with Wright's stain.
750
Karyotypes were described according to the ISCN. 35 Remain-(a 3.5-kb EcoRI fragment, kindly provided by TH Rabbitts, MRC, Cambridge, UK) mapped to the T cell receptor ␦ locus ing methanol/acetic acid fixed cells were stored at −20°C until used. on 14q11. The C␦ probe served as an internal control and was selected because neither cytogenetics nor CGH analysis revealed changes involving the region 14q11 in any of the patients. The hybridization signals were quantitated by densiFluorescence in situ hybridization tometric analysis using a Phosphor Imager and Image Quant 3.0 software (Molecular Dynamics, Sunnyvale, CA, USA). The FISH was performed in all cases with available fixed cells where CGH and cytogenetic data were discrepant. In amplification factors were calculated as a ratio of a BCL2, BCL6 or CMYC hybridization signal, respectively, to a C␦ sigaddition, cases with a normal karyotype or with insufficient mitotic yield were screened with alpha-satellite probes spenal normalized to the respective ratio observed in placenta, which was referred to an amplification factor of 1. cific for chromosomes 3 and 18, respectively (these chromosomes were found to be most frequently gained by CGH). The Additionally, gene rearrangement studies for the immunoglobulin heavy and light chain genes, T cell receptor genes, following DNA probes were used: alpha-satellite probes specific for chromosome 2 (D2Z), 3 (D3Z1), 9 (D9Z1), 11 BCL1, BCL2, BCL3, BCL6 and CMYC genes were performed in all cases as previously described.
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(D11Z1), 18 (D18Z1) and X (DXZ1), respectively (all from Oncor, Gaithersburg, MD, USA); a library probe for chromosome 18 (WCP 18, Vysis); yeast artificial chromosome (YAC) clones 886A4 (mapped to 6p21), 309G6 (1q31), 766F8 (3q27-Results 28), 928C1 (7q31); and cosmid clones B5-2 (3q27) mapped to the BCL6 gene (kindly provided by Dr T Miki, Tokyo Medical and Dental University, Tokyo, Japan) and c53. 2 (17p13) Clinical data mapped to the P53 gene (isolated from the human genomic library CMLW-25383, kindly provided by Dr E Schoenmakers, Clinical data are summarized in Table 1 . The 14 female and University of Leuven, Belgium). YAC inserts were amplified by 11 male patients ranged in age between 41 and 84 years Alu-polymerase chain reaction (PCR) according to a protocol (mean 60 years). Eighteen cases were studied at primary diagpublished by Lengauer and coworkers. 36 FISH was performed nosis and seven during the course of disease after treatment on stored, previously cultured, methanol/acetic acid fixed with chemotherapy (cases 5, 12, 13, 14 and 23-25) and radiocells according to standard methods as previously described. 37 therapy (cases 5 and 13). Five patients (cases 1-5) showed Slides were viewed and pictures were captured with the same extranodal disease at primary diagnosis and nine patients system as described for CGH analysis. For interphase studies, (cases 6-14) presented with nodal involvement; in the remain-500 cells were analyzed for each probe in each case. For the ing cases, the massively enlarged spleen, leading to hyperprobes used for interphase FISH, a proportion of 1-5% of cells splenism or abdominal discomfort, clearly represented the showing three hybridization signals and 4-15% of cells with main tumor burden. At diagnosis, most of the latter patients one signal was found in normal controls. Therefore, more than additionally showed bone marrow involvement with or with-5% of interphase cells bearing three hybridization signals out peripheral blood spread in the absence of lymphadenowere considered to indicate the presence of a trisomy and pathy (all cases except cases 18 and 20). more than 15% of cells with only one hybridization signal
The overall survival ranged from 4 to 228+ months. Seven were considered to indicate a monosomy of the respective of the 25 patients were deceased 4-68 months after diagnosis chromosome in the tumor cell population.
and all but one of the latter presented with stage IV disease.
Southern blot analysis Histopathology
Southern blot analysis was applied to investigate possible amplifications of the BCL2, BCL6 and CMYC genes in cases which showed amplification/over-representation of the The detailed description of all cases but eight (cases 4, 10, 13, 14, 17, 18, 20, 23) has been given previously. 22 These chromosomal regions 18q, 3q, and 8q, respectively, by CGH. Eight micrograms of tumor DNA and control placental DNA additional cases (one extranodal (orbit), three nodal, and four splenic MZBCL) as well as those previously described were were digested with the restriction endonucleases EcoRI (for BCL2 analysis), BglII (for BCL6) or PstI (for CMYC) and size composed of a mixture of cells encompassing the full spectrum of marginal zone B cells. In one case (case 10), a profractionated in different dilutions (1:1, 1:2 and 1:4) on a 0.7% agarose gel. After alkali blotting onto Hybond N+ membranes nounced plasmacytic component expressing the same light chain as the remaining tumor cell population was found. (Amersham, Buckinghamshire, UK) hybridization was carried out using DNA probes labeled with 32 P-dCTP using the ranResidual reactive follicle centers with preserved lymphocytic coronae were seen in three cases (cases 4, 14 and 17) regarddom priming method. The BCL2 gene was analyzed using probe BCL2B (a 2. and Southern blot data Irrespective of the localization of the lymphoma, material of chromosomes 3 (52% of cases), 18 (32%), X (24%) and 1q
Detailed data are given in Table 1 . For most of the non-bal-(16%) was most frequently gained, whereas losses mainly anced abnormalities, cytogenetic analysis and CGH showed involved chromosomes 17 (16%) and 9 (12%). Gain of the similar results. Additionally, CGH revealed chromosomal whole X chromosome was observed in a patient with known imbalances not detected by cytogenetic analysis in 13 cases Klinefelter syndrome and constitutional XXY abnormality (11 of 20 cases with abnormal karyotype, one of three cases (case 6); this chromosomal gain was excluded from evaluation with normal karyotype, and one of two cases with insufficient because of its constitutional nature. Most of the cases showed mitotic yield). Most of these cases revealed complex karymore than one chromosomal imbalance (mean 2.8) with overotypes including marker chromosomes and/or cytogenetically representation of chromosomes 3 and 18 being most freunidentifiable chromosomal material (cases 1, 3, 9, 12-14, quently associated (seven cases). In six cases, a single imbal-17, 18, 20 and 24) . In eight of the 13 cases, apparent discrepance was identified: gain of material of chromosomes 3 (cases ancies were further investigated with FISH (cases 5, 14, 17, 6, 15 and 18), 18 (case 7), and X (case 19) and loss of chromo-18 and 19) or Southern blot analysis (cases 1, 3, 17, 18 and some 17p (case 23).
21), and in all instances CGH data were confirmed. Gains of chromosome 1q and 8q and losses of chromosome Especially, over-representations of 18q (cases 1 and 3), 3q 17 or 17p were mainly seen in relapsed previously treated (case 18) and 8q (cases 17 and 21) could be confirmed by lymphomas (cases 5, 12, 23 and 24) or progressive lymSouthern blot using probes for the BCL2, BCL6 and CMYC phomas defined by stage IVB disease, progressive disease genes, respectively. The chromosomal gain involving the despite intensive chemotherapeutic treatment, and short region 3q26-27 (case 18) was also analyzed by interphase survival (cases 3, 17 and 21).
FISH using a BCL6/3q27-specific cosmid probe ( Figure 3 ) and Strong over-representations (у1.5) were detected in seven a YAC probe hybridizing to the region 3q27-28 distal to BCL6. instances and five patients and involved the following With both probes, between three and five hybridization sigchromosomal regions: 3q21-22 (case 3), 3q26-27 (case 18), nals were observed in the majority of interphase cells. How18q12-23 (case 3), 18q21-22 (case 1), 6p11-21 (case 14), ever, CGH did not detect trisomy 3, trisomy 18 and deletion 9q31-33 (case 3) and the X chromosome (case 8) (see thick 7q in three cases (cases 5, 25 and 18) with a low proportion bars in Figure 2 ). High-level amplifications (Ͼ2) were detected of tumor cells bearing these abnormalities (15-30%), as in two cases and involved the regions 18q21-23 (case 3) and shown by interphase FISH. 18q21-22 (case 1). Examples of the CGH experiments are given in Figure 1 .
On each of the frequently affected chromosomes, CGH Discussion analysis allowed us to delineate a minimal common region of over-or under-representation (Figures 1 and 2 ): both arms of The rapidly growing number of studies applying the recently chromosome 3 were over-represented in eight cases, whereas
introduced CGH technique impressively demonstrate the in four cases only the long arm was involved (cases 3, 14, 15 potential of this approach to detect chromosomal gains and and 18). Two cases showed a partial gain of 3q affecting the losses in tumor genomes.
32, [39] [40] [41] [42] [43] [44] regions 3q21-23 (case 1) and 3q25-29 (case 18), respectively. Using CGH, we identified novel genetic abnormalities On chromosome 18, the commonly over-represented region including high-level amplifications involving the chromowas mapped to bands 18q21-23, defined by three cases (cases somal region 18q and regions commonly affected by gain or 1, 3 and 12), two of which showed a high-level amplification loss of genetic material in 25 cases with MZBCL. In extranoin this region (cases 1 and 3). For chromosomes X and 1, a dal, nodal, as well as splenic MZBCL, material of chromoconsensus region of overlap in Xp22 and 1q25-31, respectsomes 3 (52% of cases), 18 (32%), X (24%), and 1q (16%) ively, could be defined. Two cases (cases 17 and 21) showed was most frequently gained, whereas losses predominantly over-representation of 8q with a common region in 8q22-24.
involved chromosomes 17 (16%) and 9 (12%). The regions commonly involved by loss of genetic material
The frequent involvement of chromosome 3 is in accould be delineated to the short arm of chromosome 17 (cases cordance with previous cytogenetic and FISH stud-3, 5, 17 and 23), the regions 9p13 (cases 1 and 3) and 7q32-ies. [15] [16] [17] 19, 20, 22, 23, 26 Interestingly, in four of our 13 cases with 36 (cases 3 and 21), and chromosome 19 (cases 3 and 17).
over-representation of chromosome 3, only material of the long arm was found to be gained with two cases showing partial gain of 3q affecting the regions 3q21-23 and 3q25-29, Southern blot analysis respectively. These data indicate that the latter regions are of particular importance and might point to genes involved in the pathogenesis of MZBCL. Several candidate genes are Gene amplification studies confirmed CGH results in all instances. The following amplification factors were found: 2.1 located on these chromosomal regions, eg a gene coding for the surface antigen B7, which can enhance CD28-mediated (case 1) and 2.0 (case 3) for BCL2; 2.7 (case 18) for BCL6; and 1.9 (case 17) and 2.1 (case 21) for CMYC (data not shown).
T cell interactions and thereby increase the production of various lymphokines, particularly interleukin 2; 45 the PBX2 All cases showed rearrangement of the immunoglobulin heavy chain locus. C (cases 4, 6, 9-11, 13, 15, 17-19, 21- homeobox gene located on 3q22-23; 46 a gene coding for a subunit of interleukin 12; 47 and the BCL6 proto-oncogene 24) or C (cases 1-3, 5, 7, 8, 12, 14, 16, 25 ) light chain gene rearrangements were found in 14 and 10 cases, respectively. mapped to 3q27, which is frequently rearranged in diffuse present study). In the present study, BCL2 protein expression was observed in 16 of the 21 cases investigated including six of seven analyzed cases with over-representation of chromosome 18 and 10 of 14 cases without copy number changes of chromosome 18.
Another proto-oncogene on 18q21 is the FVT1 gene (follicular lymphoma variant translocation 1 gene), which maps 10 kb 5Ј to BCL2. 50 It is also worth mentioning, that an as yet unidentified gene on 18q21 is involved in a translocation (11;18)(q21;q21), which has been described in one case of gastric MALT lymphoma 17 and two other extranodal lymphomas of possible marginal zone origin. 27 Further studies are necessary to identify the target gene(s) of the 18q21-23 over-representation.
In the present study, gains of chromosomes 1q and 8q and losses of chromosome 17 or 17p were predominantly observed in relapsed lymphomas or progressive, clinically advanced lymphomas with an unfavorable prognosis, indicating that these chromosomal changes are likely of secondary nature.
Figure 3
Fluorescence in situ hybridization in case 18 using a during disease progression and three deceased 4-12 months after detection of the abnormality. CGH allowed us to narrow the consensus region of overlap to 1q25-31. large cell lymphomas arising at extranodal sites. 48 Rearrangements of the BCL6 gene have not been detected in MZBCL Two cases showed over-representation of 8q with a common region in 8q22-24 containing CMYC. Both patients (Ref. 22 and present study) 2 and amplification of this gene has, to the best of our knowledge, not been described so far in any presented with stage IVB disease and died 12 and 13 months, respectively, after diagnosis due to rapid disease progression. disease entity. Using Southern blot analysis with a probe for the BCL6 gene, we found a 2.7-fold over-representation in a Amplification of CMYC has mainly been reported in solid tumors, 55 but also in some cases of chronic lymphocytic leucase with a chromosomal gain involving the region 3q26-27. Further investigations with FISH using probes for BCL6 and a kemia 40, 56 and follicle center cell lymphoma, 42 demonstrating that its activation via amplification represents a mechanism of region in 3q27-28 distal to BCL6 showed with both probes between three and five hybridization signals in the majority disease progression in a wide spectrum of malignant disorders. of interphase nuclei, underlining that the BCL6 gene is only a part of the over-represented region. In this respect, it is interLoss of material of chromosome 17, especially of 17p, was the most frequent chromosomal loss observed in the present esting to note that by immunohistochemistry only three of our cases showed a weak BCL6 protein expression and that there study. In two cases investigated by FISH, only one hybridization signal for a P53/17p13.1-specific probe was found in was no apparent correlation between over-representation of the chromosomal region 3q and expression of the BCL6 the majority of interphase cells. All patients had relapsed with rapidly progressive lymphoma. In accordance with our findprotein.
Gain of material of chromosome 18 was observed in eight ings, alterations involving 17p or P53 have been associated with disease progression and resistance to treatment in a varof the 25 cases. The commonly over-represented region could be delineated to bands 18q21-23. Two cases showed highiety of lymphoid malignancies. [57] [58] [59] [60] [61] Alterations of P53 have also been described in a considerable proportion of gastric level amplifications in this region, which were confirmed by Southern blot analysis using a probe for the BCL2 gene on MALT lymphomas 31, 62 and splenic lymphomas of possible marginal zone origin 28 and have been associated with high18q21.3. Interestingly, the regions 18q21-23 44 and 18q21-22 42 were also found to be commonly gained in two recent grade transformation of gastric MALT lymphomas. 31 Comparing the CGH results with data obtained by karyo-CGH studies investigating diffuse large cell lymphoma and follicle center cell lymphoma, respectively. Monni and typic analysis, overlapping results were found for most of the non-balanced abnormalities. Additionally, in 13 of the 25 coworkers 44 demonstrated amplification but no rearrangement of BCL2 by Southern blot in all six cases with gain of 18q. The cases, CGH revealed chromosomal imbalances, which were not detected by conventional cytogenetic analysis, but could pathogenetic significance of BCL2 amplification is not known. Rearrangement of this gene by juxtaposition to regulatory be confirmed by FISH or Southern blot analysis in all cases subsequently investigated. Most of these cases revealed comsequences of the immunoglobulin genes is known to result in BCL2 overexpression leading to inhibition of apoptosis and plex karyotypes including marker chromosomes and/or cytogenetically unidentifiable chromosomal material. On the thereby conferring a survival advantage to the affected cells.
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gene rearrangement or the corresponding other hand, CGH failed to detect trisomy 3, trisomy 18, and deletion 7q in three cases with a low number of tumor cells t(14;18)(q32;q21) are found in the majority of follicle center cell lymphoma, in contrast to MZBCL where this rearrangebearing these abnormalities (15-30%), as shown by interphase FISH. Similar discrepancies have been described prement has not been detected so far (Refs 3, 16, 22, 28, 29 and 
